Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Mroh9em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Mroh9em1/Cya

Common Name
Mroh9-KO
Product ID
S-KO-18957
Backgroud
C57BL/6JCya
Strain ID
KOCMP-78258-Mroh9-B6J-VC
Status
Research and Development
When using this mouse strain in a publication, please cite “Mroh9-KO Mouse (Catalog S-KO-18957) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Mroh9-KO
Strain ID
KOCMP-78258-Mroh9-B6J-VC
Gene Name
Mroh9
Product ID
S-KO-18957
Gene Alias
Armc11, 4921528O07Rik
Background
C57BL/6JCya
NCBI ID
78258 (Mouse)
Modification
Conventional knockout
Chromosome
Chr 1 (Mouse)
Phenotype
MGI:1925508
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000096608
NCBI Transcript ID
NM_030071
Target Region
Exon 8
Size of Effective Region
~0.1 kb
Overview of Gene Research
Mroh9 is a gene that has been associated with multiple biological processes and diseases. While its exact essential function and associated pathways are not comprehensively detailed in the provided references, it has been implicated in the oncology process for pancreatic adenocarcinoma (PAAD) patients, suggesting its potential importance in cancer-related biological functions [2]. Additionally, positional gene mapping of an associated transient ischaemic attack polygenic risk score identified the Mroh9 locus, indicating a possible role in immune and coagulation-related pathways in the pathogenesis of cranial ischaemic complications in giant cell arteritis patients [3].

In a study on circular RNAs in lung cancer patients with chronic obstructive pulmonary disease (COPD), hsa-MROH9_0001, a circular RNA potentially related to Mroh9, was positively correlated with plasma cells. This finding implies that Mroh9-related circular RNAs might play a role in the immune cell infiltration process in the context of lung cancer with COPD [1]. In the research on PAAD, Mroh9 was identified among genes potentially related to the oncology process for PAAD patients, showing its possible significance in pancreatic cancer-associated biological mechanisms [2]. For giant cell arteritis, the identification of the Mroh9 locus through positional gene mapping suggests its involvement in the pathogenesis of cranial ischaemic complications, possibly via immune and coagulation-related pathways [3].

In summary, Mroh9 seems to be involved in multiple disease-related biological processes, including immune cell infiltration in lung cancer with COPD, the oncology process in PAAD, and the pathogenesis of cranial ischaemic complications in giant cell arteritis. Although direct gene-knockout or conditional-knockout mouse model-based findings are lacking in the provided references, the existing research indicates its potential importance in these disease areas, which may guide future in-vivo functional studies.

References:
1. Li, Xiaoou, Shen, Yongchun, Cheng, Jiahan, Liu, Lunxu, Wen, Fuqiang. . Differential expression profiles and functional prediction of circular RNAs in lung cancer patients with chronic obstructive pulmonary disease: a pilot study. In General physiology and biophysics, 43, 273-289. doi:10.4149/gpb_2024013. https://pubmed.ncbi.nlm.nih.gov/38953571/
2. Wu, Zixuan, Huang, Xuyan, Cai, Minjie, Huang, Peidong, Guan, Zunhui. 2022. Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma. In Aging, 14, 869-891. doi:10.18632/aging.203846. https://pubmed.ncbi.nlm.nih.gov/35077391/
3. Chaddock, Natalie J M, Harden, Charlotte J, Sorensen, Louise, Iles, Mark M, Morgan, Ann W. 2025. Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis. In Annals of the rheumatic diseases, 84, 329-340. doi:10.1136/ard-2024-225515. https://pubmed.ncbi.nlm.nih.gov/39919905/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research